Evidence map›Paper›PMID 37915952›Full record

ArticleFrontiers in neurorobotics2023

An autonomous mobile robot path planning strategy using an enhanced slime mold algorithm.

Ling Zheng, Chengzhi Hong, Huashan Song, Rong Chen

Abstract read
In one paragraph

Article in Frontiers in neurorobotics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ling ZhengSchool of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan, China.
Chengzhi HongState Key Laboratory of Information Engineering in Surveying, Mapping, and Remote Sensing, Wuhan University, Wuhan, China.
Huashan SongSpace-Time Information Department, China Mobile Intelligent Mobility Network Technology Co., Ltd., Wuhan, China.
Rong ChenInstitute of Traffic Engineering, Wuhan Technical College of Communications, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Autonomous mobile robot encompasses modules such as perception, path planning, decision-making, and control. Among these modules, path planning serves as a prerequisite for mobile robots to accomplish tasks. Enhancing path planning capability of mobile robots can effectively save costs, reduce energy consumption, and improve work efficiency. The primary slime mold algorithm (SMA) exhibits characteristics such as a reduced number of parameters, strong robustness, and a relatively high level of exploratory ability. SMA performs well in path planning for mobile robots. However, it is prone to local optimization and lacks dynamic obstacle avoidance, making it less effective in real-world settings. Methods: This paper presents an enhanced SMA (ESMA) path-planning algorithm for mobile robots. The ESMA algorithm incorporates adaptive techniques to enhance global search capabilities and integrates an artificial potential field to improve dynamic obstacle avoidance. Results and discussion: Compared to the SMA algorithm, the SMA-AGDE algorithm, which combines the Adaptive Guided Differential Evolution algorithm, and the Lévy Flight-Rotation SMA (LRSMA) algorithm, resulted in an average reduction in the minimum path length of (3.92%, 8.93%, 2.73%), along with corresponding reductions in path minimum values and processing times. Experiments show ESMA can find shortest collision-free paths for mobile robots in both static and dynamic environments.

Indexed as

artificial potential fieldautonomous mobile robotsdynamic environmentpath planningslime mold algorithm

Identifiers

PMID37915952
PMCPMC10616528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.